Advances in the macrolides and quinolones.

doi:10.1016/s0891-5520(05)70203-8

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Back to search

Article

Advances in the macrolides and quinolones.

Infectious disease clinics of North America - 1 Sept 1998

Boswell F J, Wise R

Abstract excerpt

The widespread, frequent clinical use of the macrolides and quinolones has led to resistance in several species. With the prevailing increase of resistance, new developmental compounds with improved spectra, pharmacokinetics, and reduced adverse effects are required, coupled with logical use of t...

Topics

4-Quinolones
Anti-Bacterial Agents
Anti-Infective Agents
Bacteroides fragilis
Chlamydophila pneumoniae
DNA Topoisomerases, Type II
Drug Resistance, Microbial
Genes, Bacterial
Gram-Negative Aerobic Rods and Cocci
Gram-Positive Cocci
Haemophilus influenzae
Legionella pneumophila
Macrolides
Mutation
Mycoplasma pneumoniae
Structure-Activity Relationship

Source

Open in PubMed

Identifiers

PMID: 9779383
DOI: 10.1016/s0891-5520(05)70203-8

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 30 Aug 2026. Prepared record publication-9779383-2026-08-30.1. Manifest publication-graph-cohort-2026-08-30.1.

Source receipt: PubMed via Helena Literature Corpus, retrieved 30 Aug 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

discussions

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics